volvovaginitis.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: married Presence of candida vaginit infection in interview and confirmation with laboratory study
Exclusion criteria
Exclusion criteria: The presence of vaginal Simultaneous Sensitivity to colotrimazole cream Abnormal vaginal bleeding Pregnancy Use of immunsuppressive drugs and antibiotics, corticosteroid and birth control pills Cure chronic diseases such as diabetes, heart disease, and high blood pressure. thyroid disorder and Epilepsy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improve symptoms and severity. Timepoint: Before the start of the study, 7 and 30 days after the start of treatment with aphrodisiac (Abuhlsa) and coltrimazole 1%. Method of measurement: Clinical symptoms, Pap smear and culture of vaginal discharge. | — |
Countries
Iran (Islamic Republic of)
Contacts
Ahvaz University of Medical Sciences